Dysregulation of growth factor signaling in human hepatocellular carcinoma.
about
Activins and activin antagonists in hepatocellular carcinomaHepatocellular carcinoma: Will novel targeted drugs really impact the next future?Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinomaTargeting Wnt/β-catenin pathway in hepatocellular carcinoma treatmentEvaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingCurrent and future treatments for hepatocellular carcinomaMicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocalityOverexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liverMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsResearch progress in the radioprotective effect of the canonical Wnt pathwayFatty acid esters of phloridzin induce apoptosis of human liver cancer cells through altered gene expressionThe Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat ModelsAsian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Altered {beta}-catenin accumulation in hepatocellular carcinomas of diethylnitrosamine-exposed rhesus macaquesc-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion.Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53Bax inhibitor-1 down-regulation in the progression of chronic liver diseases.Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrenceHepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1.MiR-145 mediates zebrafish hepatic outgrowth through progranulin A signaling.Regorafenib: an evidence-based review of its potential in patients with advanced liver cancerExpression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study.TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancerILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progressionCancer gene discovery in hepatocellular carcinomaNf2/Merlin controls progenitor homeostasis and tumorigenesis in the liverEnhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cellsIGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma.Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysisSalirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.Experimental models of hepatocellular carcinomaProgranulin A-mediated MET signaling is essential for liver morphogenesis in zebrafish.Potential therapeutic role of Tridham in human hepatocellular carcinoma cell line through induction of p53 independent apoptosisEpithelial-to-mesenchymal transition of murine liver tumor cells promotes invasionNovel therapeutic strategies for targeting liver cancer stem cells.A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase.Direct association of heat shock protein 20 (HSPB6) with phosphoinositide 3-kinase (PI3K) in human hepatocellular carcinoma: regulation of the PI3K activity.Minimal cooperation between mutant Hras and c-myc or TGFα in the regulation of mouse hepatocyte growth or transformation in vivo.
P2860
Q24646221-E1B9A0ED-38A6-4461-8AB4-2F4BF14B5DADQ26741201-317C41A2-74EF-44D1-92F0-A4E96A11C099Q26766068-6BA10631-6D08-4B79-8623-1C75F53D1997Q26774623-906E88FF-2DA4-48CA-A1A7-B8D0F7D265FAQ26783895-00515470-8AFC-4812-AA1B-314DF57B9C71Q26801211-F3DF424D-DB04-4959-93E6-5137C49A85ABQ28115464-2041B198-978E-4ABD-BA9A-E64E0A040994Q28246572-3DEDCA72-4B75-4407-AB6F-F0F9048BCF85Q28383646-9A17CFF9-8D26-4778-84DE-84F336CF008FQ28386021-4DF10E76-7528-413F-84F7-FD3DE14E8D4AQ28543028-724FC8E8-FDA7-4DD9-A713-1379A3AEDA7CQ28820734-AC4AFBE9-7DBE-4588-B895-60ABA08D999AQ30479629-3A611241-9280-4BEF-B963-800CD834C6A2Q33382038-29D0D029-49F9-470C-AE45-69A15691B5C8Q33384492-23B5DE93-C49F-4165-AE3E-49D1A7195915Q33411986-88E9F8AE-4491-412E-860D-454934EFEE85Q33464737-91E7D88B-2028-403D-935B-9C2EDFA11D72Q33548519-2F36A992-E6E4-4642-AB49-F0F8265E7557Q33556420-30417E6B-EC4F-4FF5-81BF-EFEEB0B2F63FQ33590801-82C68187-429D-44AA-BC69-7E1AFA8C4075Q33713078-2A0F3B58-C465-4796-92EA-AC98A1F8C479Q33944599-5C3CDC25-66B5-479A-809B-F6C5FFAA9189Q33957406-D7FB9CC4-7C15-4F4C-A261-19D741E39486Q33965228-37036AC3-63EB-43CC-9D9D-F3A12779384FQ33977419-2A7512C1-BEDD-4246-9729-CCDEABAFF2B2Q34002120-3C660A9F-E04A-4591-9E41-47034294E615Q34069370-FF09F840-2721-46C4-9A58-D565BAA52167Q34081570-4279F175-3972-46D1-93C0-D87681AA0087Q34102411-B116C48E-6EB4-44AB-BABB-F11AF740383CQ34186627-2BBFA15A-F75A-4313-AD56-74DBD6C3191DQ34189361-498E3D33-A4AA-4C63-8898-404D4B93F7F5Q34202856-77DAEE69-244E-41DD-A319-8791013DA8A6Q34345987-F507E404-3C9A-4551-9652-AAD98D33FAE9Q34412775-1B4FB3DA-1EED-4FDE-86E4-26D559CFF84BQ34464794-75651554-44D1-46D6-93B3-2E8F8EB6BE85Q34545548-EF3D82B2-FCCA-4816-99BA-B06FA7A3B9BFQ34940971-122C8FCA-4614-48DF-B58B-CABD674D67D8Q35038107-B3766BB9-05D0-4513-BA32-1546619D2B20Q35040191-079FD089-E951-474B-AE5B-F2F5A086C05BQ35049640-4EA5F7C9-E9A5-4F4C-AD18-738708787C60
P2860
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
@ast
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
@en
type
label
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
@ast
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
@en
prefLabel
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
@ast
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
@en
P356
P1433
P1476
Dysregulation of growth factor signaling in human hepatocellular carcinoma
@en
P2093
Longerich T
Schirmacher P
P2888
P304
P356
10.1038/SJ.ONC.1209556
P407
P50
P577
2006-06-01T00:00:00Z